In The Lancet Infectious Diseases, Fernando Abad-Franch and colleagues1 present the results of a study that used distributions in case data to assess the effect of mosquito-disseminated pyriproxyfen ...

The team engineered genes to code for the RING constructs and delivered them to mice using an adenovirus vector, commonly ...

D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

The TRIM21 therapies have been shown to remove toxic tau proteins and reduce symptoms of neurodegeneration in mice.

For example, TP53, which encodes multiple proteins, is the most commonly mutated gene in cancers. To address this, Fajac et al. used genome editing to make mouse strains that were still able to ...

Genetic modification in horticultural crops, particularly within the Cucurbitaceae family, is often hindered by complex ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 ...

Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm’s clinical program is a LVV-based gene therapy for ...

The company said the single-arm multicenter Phase II trial may support accelerated approval for the RP-A501 gene therapy in the US.

At Princeton University, scientists have been nudging DNA by using light-inducible biomolecular condensates to generate capillary forces at targeted DNA loci. These condensates are part of a platform ...